Clinical utility of serial plasma cell-free DNA metagenomic next-generation sequencing assays

By afschroeder • January 14, 2026

Kaur I, Shaw B, Multani A, Malhotra S, Dong HV, Lukose C, Prabaker K, Saleh T, Sim YB, Tymchuk CN, Uslan DZ, Zhou H, Brewer TF, Yang S. Clinical utility of serial plasma cell-free DNA metagenomic next-generation sequencing assays. Infect Control Hosp Epidemiol. 2026 Jan 13:1-3. doi: 10.1017/ice.2025.10390. Epub ahead of print. PMID: 41527828.

Tags: clinical utility, diagnostic stewardship, General Internal Medicine, Hospitalist, Infectious Diseases, Karius test, metagenomic next-generation sequencing, Plasma cell-free DNA, Publications, Resident, serial testing

William J. Carroll, MD, FACP Appointed Section Chief of Palliative Care and Extensivist Medicine

The UCLA Department of Medicine (DoM) is pleased to announce the appointment of William J. Carroll, MD, FACPas section chief of the UCLA DoM Palliative Care[...]

Joshua N. Khalili, MD Appointed to DoM Chief Wellness Officer

The UCLA Department of Medicine has appointed Joshua N. Khalili, MD to chief wellness officer (CWO) effective April 1. The appointment builds on Dr. Khalili’s outstanding work[...]

Sun M. Yoo, MD, MPH to Depart DoM to Pursue New Leadership Opportunity

The UCLA Department of Medicine (DoM) announces that Sun M. Yoo, MD, MPH, will be departing UCLA Health to assume the role of a founding chief[...]